Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEOP/IVE/GDP vs CEOP in Newly Diagnosed PTCL
NCT02533700Phase 2Unknown
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Sep 2015
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifosfamide, etoposide, gemcitabine, cisplatin in peripheral T-cell lymphoma (PTCL), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Status: unknown.
02
Drugs
ifosfamideetoposidegemcitabinecisplatin
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02533700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02533700.